In this episode, Akin Gump health care and life sciences counsel Taylor Jones and Matt Wetzel discuss the Justice Department’s recent guidance on evaluation of corporate compliance programs.

Among the topics covered:

·         Incorporating the guidance into risk assessment.

·         Its impact on the health care sector.

·         What it may reveal about DOJ compliance strategy.

·         Top takeaways.

For more information on Akin Gump’s health care and life sciences work, please visit the health care and life sciences page on akingump.com.